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Abstract
Women with renal disease progress at a slower rate to end stage renal disease
than men. As angiotensin II has both hemodynamic and direct renal effects,
we hypothesized that the female protection may result from gender differences
in responses to angiotensin II. Therefore, we studied gender differences in
response to angiotensin II, during acute (human) and chronic (rats) angioten-
sin II administration. In young healthy men (n = 18) and women (n = 18)
we studied the responses of renal hemodynamics (125I-iothalamate and
131I-Hippuran) and blood pressure to graded angiotensin II infusion (0.3, 1.0,
and 3.0 ng/kg/min for 1 h). Men had increased responses of diastolic blood
pressure (P = 0.01), mean arterial pressure (P = 0.05), and a more pro-
nounced decrease in effective renal plasma flow (P = 0.009) than women. We
measured the changes in proteinuria and blood pressure in response to
chronic administration (200 ng/kg/min for 3 weeks) of angiotensin II in rats.
Male rats had an increased response of proteinuria compared with females
(GEE analysis, P = 0.001). Male, but not female, angiotensin II-treated rats
had increased numbers of renal interstitial macrophages compared to sham-
treated rats (P < 0.001). In conclusion, gender differences are present in the
response to acute and chronic infusion of angiotensin II. Difference in angio-
tensin II sensitivity could play a role in gender differences in progression of
renal disease.
Introduction
Women generally have a lower risk for developing cardio-
vascular disease (CVD) and chronic kidney disease
(CKD) than men. They also progress slower to end stage
renal disease (ESRD) after a renal insult (Silbiger and
Neugarten 1995). The renin-angiotensin aldosterone sys-
tem (RAAS), with angiotensin II (ang II) as a principal
effector, is an important mediator of renal and cardiovas-
cular physiology and pathophysiology with hemodynamic,
pro-inflammatory, and pro-fibrotic effects. Thus, differ-
ences in responsiveness to ang II might provide a possible
explanation for the gender difference in progression to
renal disease. Indeed, in the last few years gender differ-
ences in the components and regulation of the RAAS
have been recognized to be of functional importance (Sul-
livan 2008; Hilliard et al. 2013).
Elucidation of gender differences is important, since this
may translate into gender-specific treatment and subse-
quently to better outcomes in men and women. The
importance of such studies is supported by the evidence
suggesting gender differences in the efficacy and effects of
anti-hypertensive medication in general and more specifi-
cally in RAAS blockade (Ruggenenti et al. 2000; Falconnet
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et al. 2004; Franconi et al. 2007; Hudson et al. 2007). In
cardiovascular studies, women appear to be less responsive
to angiotensin-converting enzyme inhibition (ACE-i) than
men (Falconnet et al. 2004; Hudson et al. 2007), while
proteinuric women responded better to treatment with
ACE-i than men (Ruggenenti et al. 2000). Men require
larger doses of ang II type 1 receptor (AT1-R) blocker to
achieve the same blood pressuring lowering effect as
women (Miller et al. 2006). These results illustrate the
importance of a better understanding of the effect of gen-
der differences in the RAAS.
Human gender differences in RAAS function have also
been observed in responsiveness to ang II infusion. Two
studies in healthy normotensive men and women (Gandhi
et al. 1998; Miller et al. 1999) showed differences in the
renal responsiveness to graded ang II infusion, whereas
blood pressure responses were similar, pointing toward
specific renal differences between men and women. Both
studies, however, did not study women at a fixed time-
point of the menstrual period. It is well known that this
may be of great influence on both the RAAS and renal he-
modynamics. Indeed, Miller et al. showed that baseline
characteristics for blood pressure, effective renal plasma
flow (ERPF), renal blood flow (RBF), filtration fraction
(FF), and renal vascular resistance (RVR) are affected by
17ß-estradiol concentrations (Miller et al. 1999). More-
over, they also showed that 17ß-estradiol concentrations
affected the response of ERPF and aldosterone to ang II
infusion (Miller et al. 1999). Therefore, it is important to
standardize the time-point of the menstrual cycle in small
physiological studies.
To substantiate, however, the relevance of differences
in the RAAS for the susceptibility to chronic renal dam-
age, it is crucial to demonstrate differences in responsive-
ness to chronic ang II administration as well. This is
cumbersome to study in humans. Available animal data
on ang II infusion so far also show increased responsive-
ness to angiotensin in males compared with females
(Sampson et al. 2008; Tatchum-Talom et al. 2005; Xue et
al., 2005; Ebrahimian et al. 2007). Whether the effects of
chronic ang II infusion on proteinuria are also sex depen-
dent has not been studied.
Therefore, in the present translational study we
combined human and animal experiments to investigate
gender differences in the response to ang II. In healthy
young men and women (during mid-follicular phase) on
standardized sodium intake, we studied the responses of
blood pressure and renal hemodynamics to an acute
graded ang II infusion. The effects of ang II on blood
pressure, proteinuria, and morphological markers of pro-
inflammatory pathways and fibrosis in the kidney were
studied in healthy young male and female rats after




The study population was recruited from the ongoing
Groningen Renal Hemodynamic Cohorts (GRECO) pro-
gram. The GRECO program hosts and harmonizes stud-
ies on renal hemodynamics at the renal function unit of
the University Medical Center Groningen, by standardi-
zation of methodology, including harmonization of
study protocols and calibration over time. This allows
combined analyses in subjects from different substudies.
The current study population consisted of 36 healthy,
Caucasian subjects (women, n = 18; men, n = 18).
Women were studied in the RETAP project, and com-
pared with men from the Gene-Environment project
(Lely et al. 2010; Visser et al. 2008a,b). For the parame-
ters used in the present study, the protocols were
prospectively designed to be identical in design and
measurements. All subjects were nonsmokers and
normotensive, had a sitting systolic blood pressure <
140 mmHg and diastolic blood pressure < 90 mmHg
measured by an automatic sphygmomanometer (Dina-
map, GE Medical Systems, Milwaukee, WI) and were
not treated with antihypertensive medication. Their
medical history revealed no significant diseases. Subjects
with obesity (BMI>30 kg/m2 at screening) were
excluded. Physical examination and electrocardiography
did not reveal any abnormalities. None of the women
were users of oral contraceptive medication. Both studies
were approved by the local medical ethical committee
(METc number: RETAP study 2010/294, Gene-Environ-
ment study 2001/012), and all subjects gave written
informed consent in accordance with the Declaration of
Helsinki. The RETAP study was registered in the Neth-
erlands National Trial Register (www.trialregister.nl; trial
registration number: 2635) as REsponse To Angiotensin
II in formerly Preeclamptic women (RETAP) study.
Study protocol
The study protocol consisted of a 7-day period on a stan-
dardized sodium diet (aim: 200 mmol Na+/day). For
assessment of dietary compliance and the achievement of
a stable sodium balance, 24 h-urine was collected at day 3
and day 6. As both renal hemodynamics and ang II
responsiveness are greatly influenced by female sex
hormones (Pechere-Bertschi and Burnier 2004), all mea-
surements in women were performed during the mid-fol-
licular phase (day 7  2 of menstrual cycle). At day 7 of
the study protocol, the subjects reported at the research
unit at 8 am after an overnight fast. Body weight, length
2015 | Vol. 3 | Iss. 7 | e12434
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and waist-to-hip ratio were measured at the start of this
day. Intravenous cannulas were inserted into both fore-
arms, one for drawing blood samples, the other for
infusion of ang II. Subjects received standardized meals
and fluids during the day, with sodium intake adjusted to
the prescribed diet. To ensure sufficient urine output,
infusion of 250 mL/h of 5% glucose was administered
and every hour 250 mL of oral fluids were provided.
Glomerular filtration rate (GFR) and ERPF were
measured from the clearance of constantly infused
radio-labeled tracers, 125I-iothalamate and 131I-Hippuran,
respectively, in semi-supine position in a quiet room.
After drawing a blank blood sample, a priming solu-
tion, containing 0.04 mL/kg body weight (0.04 MBq of
125I-iothalamate and 0.03 MBq of 131I-Hippuran per
milliliter saline) plus an extra bolus of 0.06 MBq of
125I-iothalamate was given, followed by constant infusion
at 12 mL/h of the same solutions. After a 2 h stabiliza-
tion period, stable plasma concentrations of both tracers
were attained, and the clearance periods started. The
clearances were calculated using the formula U*V/P for
GFR and I*V/P for ERPF. U*V represents the urinary
excretion of the tracer, I*V represents the infusion rate
of the tracer, and P represents the tracer value in plasma
at the end of each clearance period. The urinary clear-
ance of 125I-iothalamate was multiplied by the ratio of
plasma-to-urinary clearance of 131I-hippuran to correct
for voiding errors (Apperloo et al. 1996; Visser et al.
2008a,b). GFR and ERPF were indexed for body surface
area (BSA), by dividing the raw sample by BSA and
multiplying it with 1.73 m2. BSA was calculated accord-
ing to the DuBois-DuBois formula (Du Bois and Du
Bois 1989).
Blood pressure and heart rate were measured by using
an automated sphygmomanometer (Dinamap; GE Med-
ical Systems). The appropriate blood pressure cuff was
determined on the basis of arm circumference. Mean
arterial pressure (MAP) was calculated as diastolic pres-
sure plus one-third of the pulse pressure.
Baseline values for blood pressure, GFR and ERPF were
obtained from 10 am to 12 pm at 15 min intervals.
Between 12 pm and 3 pm ang II (Clinalfa, Merck Bio-
sciences AG, L€aufelfingen, Switzerland) was administered
intravenously at a constant rate in doses of 0.3, 1 and
3 ng/kg/min each during 1 h. During these ang II infu-
sions blood pressure was measured at 5-min intervals.
Urine sampling and analysis
Urine samples were drawn from the 24 h-urine collected
by all subjects. The levels of urinary sodium, potassium,
and urea were assessed by an automated clinical chemistry
analyzer (Roche Modular, Basel, Switzerland).
Animal experiments
Experimental set up
Experiments were conducted under protocols approved
by the Animal Ethical Committee of the University of
Groningen. Four-month-old female (n = 25) and male
(n = 19) Wistar rats (Harlan Inc, Horst, the Netherlands)
were kept in a 12-h light–dark cycle and constant room
temperature, with food and water freely available in the
home cages. Both female and male rats were divided in
two groups: one sham-pump-treated group (control;
female, n = 14; male, n = 10), and one group receiving
ang II infusion continuously via an osmotic minipump
(female, n = 11; male, n = 9). The infusion rates of ang
II infusion were similar between males and females, that
is, we infused ang II at a rate of 200 lg/min/kg (ang II in
saline containing 0.01 N acetic acid). For minipump
implantation rats were anesthetized with isoflurane and
oxygen and minipumps were implanted intraperitoneally
(Alzet, Cupertino, CA, model 2004). In all rats, blood
pressure and proteinuria were measured at baseline (day -
1, i.e. before minipump implantation) and at weekly
intervals after pump implantation (days 7, 14, and 21).
Subsequently, after 3 weeks of infusion (day 21) rats were
sacrificed and the left kidney was collected. Parts of the
kidney were harvested and fixed in 4% paraformaldehyde
in PBS or snap frozen.
Measurement of blood pressure
Blood pressure was measured using an indirect tail-cuff
plethysmographic method with a blood pressure monitor
(Apollo 179; IITC Life Science, Woodland Hills, CA). All
rats were conscious during the measurements. In order to
reduce spontaneous variation in blood pressure, rats were
extensively trained for a period of 4 weeks on a daily
basis to get used to the tail-cuff method. Prior to blood
pressure readings, rats were optimally warmed using a
warmth lamp to induce vasodilation of the tail vein.
Readings were repeated 10 times and after excluding the
lowest value, the average of the lowest three values for
systolic blood pressure were used for further analysis.
Blood and urine sampling and analysis
Twenty-four-hour urine samples were collected from all
rats. To this purpose, rats were placed in metabolic cages
on days -1, 7, 14, and 21. Urinary concentration of protein
(Pyrogallol Red – Molybdate Complex) was determined as
previously described (Watanabe et al. 1986) and 24-h
excretion rates were calculated. A blood sample was taken
at sacrifice in a precooled EDTA tube (day 21) and imme-
ª 2015 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
the American Physiological Society and The Physiological Society.
2015 | Vol. 3 | Iss. 7 | e12434
Page 3
T. J. Toering et al. Gender Differences in Ang II Sensitivity
diately centrifuged at 4°C, 956 g for 10 min. Plasma was
subsequently stored at -80°C until analysis. Urinary and
plasma creatinine concentrations were determined (CREA
plus, cobas, Roche Modular) from samples collected on
day 21 and creatinine clearance was calculated according
to the standard formula ((urinary creatinine (mmol)
*1000)/plasma creatinine (lmol)*(urine volume/1440)).
Immunohistochemistry
After PFA fixation of renal tissue for 24 h, and 70%
alcohol for at least 24 h, tissue was processed for paraffin
embedding according to standard methods. For immuno-
histochemistry, 2 lm sections were cut. Total macropha-
ges/monocytes (ED-1; 1:100 diluted, AbD Serotec,
D€usseldorf, Germany) and CD206-positive macrophages
(representing type 2 macrophages; 1:1000 diluted; Abcam,
Cambridge, UK) were stained as previously described
(Melgert et al. 2012). Numbers of interstitial ED-1 and
CD206-positive cells were determined by manually analyz-
ing 30 randomly selected cortical fields per kidney (409
magnification), excluding fields with glomeruli. For each
cortical field, the number of positive cells was counted.
The prefibrotic marker for myofibroblast transforma-
tion, alpha-smooth muscle actin (a-SMA), was detected
using a murine monoclonal antibody (a-SMA; clone 1A4;
Sigma) as previously described (Rook et al. 2005). Sec-
tions stained for a-SMA were scanned using an Aperio
ScanScope CS and analyzed with Aperio ImageScope
v10.2.2.2319 (Aperio, Vista, CA). The “Positive pixel
Count V9” algorithm was used to analyze a-SMA-positive
pixels in 30 randomly selected cortical fields per kidney
after excluding vessels and glomeruli. The positive surface
area (number of positive pixels) was divided by the total
area of the field measured, providing a number of a-
SMA-positive pixels corrected for the area analyzed.
Researchers were blinded for group allocation of the rats
while analyzing the kidney slides.
Gene expression analysis
Total kidney RNA from homogenized renal cortex was
isolated with TRIzol Reagent (Invitrogen) following the
manufacturer’s instructions. Total RNA was quantified
using a NanoDrop ND1000 spectrophotometer (Nano-
Drop Technologies Inc., Wilmington, DE). cDNA synthe-
sis was performed as described before (Plosch et al. 2010).
Real-time RT-PCR was performed using Lightcycler 480
(Roche, Applied Science, Penzberg, Germany) and Applied
Biosystems reagents according to the manufacturer’s
instructions. Expression levels were normalized to those of
18S ribosomal RNA, which was analyzed in separate runs.
Primers and probes for the angiotensin II type 1 (AT1-R)
and the angiotensin II type 2 (AT2-R) receptors were
obtained from Applied Biosystems (TaqMan Gene Expres-
sion Assays, AT1-R: Rn00578456_m1 and AT2-R:
Rn00560677_m1). The sequence for 18S (M11188) (sense
primer, antisense primer, and probe, respectively; all from
50 to 30) was: CGGCTACCACATCCAAGGA, CCAATTA-
CAGGGCCTCGAAA, CGCGCAAATTACCCACTCCCGA.
Data analysis and power analysis
Statistical analysis was performed using SPSS for Windows
(Version 20.0; IBM SPSS, New York, NY). Parametric
data are presented as mean  standard deviation (SD) or
mean  standard error of the mean (SEM) in text, table,
and figures and analyzed using Student t-test. Nonpara-
metric data are presented as median (25th–75th percen-
tile) and analyzed using Mann–Whitney U-test or
Kruskal–Wallis test.
The responses to ang II infusion in humans (blood
pressure and renal hemodynamics) and rats (blood
pressure and proteinuria) were analyzed by generalized
estimating equations (GEE) analysis. Variables with a
skewed distribution were log transformed to fulfill the cri-
teria for GEE analysis. Statistical significance was accepted




Baseline characteristics of the men and women are shown
in Table 1. Age was not different between the groups. In
men body height and body weight were significantly
higher. BMI and waist-to-hip ratio were not different
between the groups. No significant differences were found
in urinary sodium, potassium, or urea excretion between
the groups, which reflect equal sodium, potassium, and
protein intake in men and women during the week of
standardized diet. At baseline, men had a significantly
higher systolic blood pressure than women, but diastolic
blood pressure and MAP were similar in men and
women. Men had a significantly lower heart rate. With
regard to renal hemodynamics, at baseline no differences
in GFR were found between the groups, but men had a
significantly higher ERPF than women.
Blood pressure response to acute ang II infusion
in men and women
The responses of blood pressure to increasing doses
of ang II infusion in men and women are shown in
2015 | Vol. 3 | Iss. 7 | e12434
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Figure 1. It shows that the lowest dose, 0.3 ng/kg/min
was a nonpressor dose, with even a significant decrease in
diastolic blood pressure compared to baseline in women.
Significant dose-dependent increases occurred during 1.0
and 3.0 ng/kg/min in both groups. During several
infusion steps, men had higher systolic blood pressure
(baseline, 0.3, 1.0 and 3.0 ng/kg/min), diastolic blood
pressure (0.3 and 1.0 ng/kg/min) and MAP (0.3, 1.0 and
3.0 ng/kg/min) than women. Analyzing the dose response
curve as a whole by GEE analysis indicated that the
responses, albeit small, were significantly different for dia-
stolic blood pressure (P = 0.01) and MAP (P = 0.05).
After correction for baseline value, the gender difference
in MAP responses became borderline significant (P =
0.08), but the gender difference in diastolic blood pres-
sure response to ang II remained statistically significant
(P = 0.01).
Renal hemodynamic response to acute ang II
infusion in men and women
Figure 2 shows the responses of GFR (panel A) and
ERPF (panel B) during ang II infusion in men and
women. Women responded to ang II infusion by a
significant decline in GFR during the 1.0 ng/kg/min and
3.0 ng/kg/min infusion rate, while men responded to
ang II by maintaining GFR at all infusion doses. At the
dose of 3.0 ng/kg/min GFR was significantly lower in
women than in men (P = 0.001). Analyzing the dose–
response curves as a whole by GEE analysis indicated
that the response was significantly different between men
and women for GFR (P = 0.01; corrected for baseline
values).
Table 1. Baseline characteristics of human subjects
Female (n = 18) Male (n = 18) P
Age, years 36  5 31  11 0.092
Height, m 171  5 184  6 <0.001
Body weight, kg 68.0  8.4 78.7  8.0 <0.001
BMI, kg/m2 23.2  2.7 23.2  2.2 0.969
Waist/Hip ratio 0.83  0.04 0.85  0.08 0.397
Urinary sodium,
mmol/24 h
221  63 200  69 0.356
Urinary potassium,
mmol/24 h
80  34 68  22 0.267
Urinary urea,
mmol/24 h
339  89 383  82 0.132
Systolic blood
pressure, mmHg
115  8 124  12 0.012
Diastolic blood
pressure, mmHg
71  8 73  8 0.403
Mean arterial
pressure, mmHg
85  8 90  8 0.098
Heart rate, p/min 67  8 57  8 <0.001
GFR, mL/min/1.73 m2 109  15 111  14 0.693
ERPF, mL/min/1.73 m2 380  69 493  78 <0.001
BMI, body mass index; GFR, glomerular filtration rate; ERPF, effec-
tive renal plasma flow.
Data are expressed as mean  SD. P-value < 0.05 is statistically
significant (bold).
A B C
Figure 1. Mean ( SD) systolic blood pressure, diastolic blood pressure and mean arterial pressure during acute angiotensin II infusion in
females (open squares) and males (closed squares). Abbreviations: SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, mean
arterial pressure. *Significantly different from baseline (Student’s t-test), P ≤ 0.05. #Significantly different from females after infusion of the
same dose of angiotensin II (student t-test), P ≤ 0.05. **Curves of males and females significantly different (GEE analysis), P ≤ 0.05. After
correction for baseline value, the gender difference in MAP responses became borderline significant (P = 0.08), gender difference in diastolic
blood pressure response to ang II remained statistically significant (P = 0.01).
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ERPF significantly and progressively decreased during
increasing doses of ang II in men and women. Analyzing
the dose–response curve as a whole by GEE analysis indi-
cated that the response was significantly different between
men and women for ERPF (P = 0.009; corrected for base-
line value).
Animal study
The baseline body weight was significantly higher in male
rats compared to female rats, while ang II treatment did
not affect body weight (males: sham-treated rats
405  18 g, ang II-treated rats 397  9 g; females: sham-
treated rats 268  18 g, ang II-treated rats 271  18 g;
P < 0.001).
Responses of blood pressure and urinary protein
excretion to chronic ang II infusion
At baseline, blood pressure did not significantly differ
between both groups. However, at baseline, male rats had
a significantly higher 24 h urinary protein excretion than
female rats (Fig. 3). In sham rats, systolic blood pressure
did not change over the 3-week treatment period in either
group (results not shown). After chronic ang II infusion
both male and female rats had a significant increase in
systolic blood pressure (Fig. 3). Male rats showed a more
rapid increase in systolic blood pressure than female rats,
reaching a plateau after 2 weeks of ang II infusion. At
that time-point, male rats had a significantly higher
systolic blood pressure than female rats.
In the sham-treated rats no significant changes in pro-
teinuria were observed during the 3 weeks of treatment
(results not shown). During 3 weeks of ang II infusion,
which was similar in males and females, both male and
female rats showed a significant increase in proteinuria,
starting after the first week (Fig. 3). After 2 and 3 weeks
of ang II infusion, male rats had a significantly higher pro-
teinuria than female rats. Furthermore, male rats had a
significantly larger increase in proteinuria compared to
baseline values than female rats (GEE analysis, interaction
between ang II response and gender, P = 0.001). When
corrected for body weight, proteinuria was still higher in
males than in females (data not shown). Creatinine clear-
ance corrected for body weight was not different between
the four groups (ang II-treated rats: male, 8.9  2.5 mL/
min/kg, female, 8.3  2.1 mL/min/kg; sham treated: male,
8.2  1.9 mL/min/kg; female, 9.2  1.9 mL/min/kg;
P = 0.544, Kruskal–Wallis test) after 3 weeks of treatment.
Responses of intrarenal inflammatory parameters
and kidney damage following ang II infusion
In order to evaluate inflammation in the kidney, we
studied the number of interstitial macrophages in the kid-
ney sections (Fig. 4A). The number of ED-1-positive
A B
Figure 2. Mean ( SD) glomerular filtration rate (A) and effective renal plasma flow (B) during acute angiotensin II infusion in females (open
squares) and males (closed squares). Abbreviations: GFR, glomerular filtration rate; ERPF, effective renal plasma flow; ang II, angiotensin
II.*Significantly different from baseline (Student’s t-test), P ≤ 0.05. #Significantly different from females after infusion of the same dose of
angiotensin II (student t-test), P ≤ 0.05. ** curves of males and females significantly different (GEE analysis), P ≤ 0.05.
2015 | Vol. 3 | Iss. 7 | e12434
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macrophages per 30 cortical fields was not different
between male and female sham-treated rats. After ang II
treatment the number of interstitial macrophages was sig-
nificantly increased as compared to sham-treated rats in
males, but not in female rats. There were no significant
differences in CD206-positive cells per 30 interstitial fields
between sham-treated males and females and no effect of
ang II infusion (data not shown).
In order to evaluate possible kidney damage, kidney
sections were stained for a-SMA (Fig. 4B). Figure 4B
shows that male sham-treated rats had significantly more
expression of interstitial a-SMA than female sham-treated
rats. In both male and female rats a significant increase in
expression of interstitial a-SMA after ang II infusion was
found as compared to the sham-treated groups. However,
after ang II infusion no differences were found between
female and male rats. There was a strong relationship
between aSMA and blood pressure at 3 weeks (R2 =
0.282, P = 0.013).
AT1 and AT2-receptor mRNA
AT1-R and AT2-R expression in kidney and aorta were
evaluated (Fig. 5A and B). No difference in mRNA
expression for AT1-R in the kidney was found between
sham-treated female and male rats and ang II infusion
did not affect AT1-R expression in the kidney either. The
mRNA expression for AT2-R in the kidney, however, was
A B
Figure 3. Median (with 25th–75th percentile) systolic blood pressure (A) and proteinuria (B) during chronic angiotensin II infusion in female
(open squares) and male (black squares) rats; *Significantly different from baseline (Mann–Whitney U-test), P ≤ 0.05. #Significantly different
from females (Mann–Whitney U-test), P ≤ 0.05. **Curves of males and females significantly different (GEE analysis: interaction between
angiotensin II proteinuria response and sex).
A B
Figure 4. Median (interquartile range) numbers of ED-1-positive cells (A) and a-smooth muscle actin expression (B) in the interstitium of the
kidney of female rats and male rats without chronic angiotensin II infusion (white bars) and with chronic angiotensin II infusion (black bars).
Abbreviations: Ang II, angiotensin II. *P ≤ 0.05 (Mann–Whitney U-test).
ª 2015 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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higher in female rats than in male rats, with again no
effect of ang II treatment.
Discussion
In this translational study we found differences in the
response to ang II infusion in both healthy human
subjects and in healthy rats. In humans, men showed an
increased blood pressure and ERPF response, and a
slightly decreased GFR response to acute ang II infusion
compared with women. We showed that chronic ang II
infusion resulted in a higher blood pressure in male com-
pared with female rats, which confirms previous studies.
However, we also showed an increased proteinuria
response to chronic ang II infusion in male rats compared
with female rats. This was previously only shown in spon-
taneous hypertensive rats (SHR; Sullivan et al., 2007).
The increased ang II response in males was associated
with more inflammation in the kidney compared with
female rats. It may be speculated that our data point
toward an increased ang II sensitivity in men, which may
be involved in the higher risk for renal damage in males
on the long term.
Our human data showed a higher blood pressure
response to acute ang II infusion in men compared with
women. These results differ from those from Miller et al.
and Gandhi et al. (Gandhi et al. 1998; Miller et al. 1999),
which might be due to differences in study protocol and
patient selection. We feel that the main difference
between our study and those of Miller and Gandhi is that
we standardized measurements by phase of the menstrual
cycle, as the latter can considerably affect RAAS-activity
(Pechere-Bertschi and Burnier 2004). We found in both
men and women the expected renal hemodynamic
response to ang II infusion, namely a decrease in ERPF.
This response is due to renal vasoconstriction, mainly in
the efferent arteriole. However, the ERPF response is
more pronounced in men compared with women. A
greater decrease in ERPF in males may reflect a larger
availability of the AT1-R, due to an upregulation of this
receptor in a less active intrarenal RAAS system (Visser
et al. 2008a,b). For GFR, the response was more
pronounced in women than in men, since women
responded to ang II by a significant decline in GFR,
whereas men responded by maintaining GFR. This find-
ing is consistent with the results of Miller et al. and it
suggests that the afferent arteriole is more sensitive to ang
II stimulation in women than in men. This different
balance between afferent and efferent vasoconstriction in
response to ang II in females compared to males could be
a protective mechanism of the female glomerulus to
prevent glomerular hypertension (Miller et al. 1999).
To evaluate the effect of chronic ang II infusion we
studied the proteinuria and blood pressure response to
3 weeks of ang II infusion in male and female rats. In
accordance with the acute effects of ang II on blood pres-
sure in our human study and with results of other rat
studies (Sampson et al. 2008; Tatchum-Talom et al. 2005;
Xue et al., 2005; Ebrahimian et al. 2007), we observed a
more rapid increase of blood pressure after ang II infu-
sion in male compared with female rats. Furthermore,
male rats also showed higher proteinuria at baseline and
an increased proteinuria response after similar chronic
ang II infusion compared with female rats. This finding
suggests an increased sensitivity of the proteinuria
response to ang II in males compared with females. To
A B
Figure 5. Median (with 25th and 75th percentile) angiotensin 1 receptor and angiotensin 2 receptor mRNA expression in the kidney (A and B
respectively) of female and male rats without chronic angiotensin II infusion (white bars) and with chronic angiotensin II infusion (black bars).
Abbreviations: ang II, angiotensin II; AT1-R, angiotensin II type 1 receptor; AT2-R, angiotensin II type 2 receptor. *P ≤ 0.05 (Mann–Whitney U-test).
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our knowledge, this is the first study showing this sex dif-
ference in proteinuria in response to chronic infusion of
ang II in healthy rats. Sullivan et al. showed the same dif-
ference in SHR rats (Sullivan et al. 2007). Moreover, oth-
ers have shown that transgenic rats bearing the mouse
Ren2 gene have sex-dependent differences in proteinuria,
with higher protein excretion in males compared to
females (Pendergrass et al. 2008). This, however, appeared
to be due to higher levels of ang II in male transgenic rats
compared with female transgenic rats, rather than to
higher ang II sensitivity. Our current data show that ang
II-induced proteinuria after chronic ang II infusion in
healthy rats is also sex dependent. The reason for the sex
difference in proteinuria is not completely understood.
Several mechanisms could be involved. It seems likely that
hemodynamic effects are involved, since the ang II-
induced blood pressure increase was more severe in males
compared with females in our study. This may cause an
increased pressure-induced injury in males compared with
females (Remuzzi and Bertani 1998).
Inflammatory processes and/or fibrosis may also be
involved in the sex differences in ang II-induced protein-
uria (Noronha et al. 2002). Interstitial macrophage influx
was different for males and females after 3 weeks of ang
II infusion; we observed increased numbers of macro-
phages after 3 weeks of ang II infusion only in males. The
increased numbers of interstitial macrophages could
either be the cause or consequence of the increased pro-
tein excretion. Excessive tubular reabsorption of protein
results in tubulo-interstitial infiltration of inflammatory
cells, especially monocytes (Remuzzi and Bertani 1998).
On the other hand, macrophages themselves have also
been shown to induce kidney damage (Anders and Ryu
2011). Thus, our data suggest a possible ang II-induced
vicious circle of renal damage which might be more
prominent in males.
Despite the higher proteinuria in males there were little
interstitial profibrotic changes in the kidney, as measured
by aSMA. These changes were not different between
males and females. In the present study, the subtle pro-
fibrotic damage after 3 weeks of ang II infusion appeared
to be blood pressure related since there was a strong rela-
tionship between aSMA and blood pressure. There was
no difference in blood pressure after 3 weeks of ang II
treatment between males and females, this may also
explain why we did not detect a sex difference in profib-
rotic kidney damage. However, we cannot exclude that
infusion of ang II of longer duration, or with higher doses
would have result in larger sex differences in proteinuria
and blood pressure and in sex differences in profibrotic
markers. This should be subject of further research.
Differences in responsiveness to ang II between males
and females could be due to difference in expression of
the AT1-R and AT2-R and in the balance between the
two. Although in the kidney the mRNA expression for
the AT1-R was not different in males and females, AT2-R
mRNA was higher in female rats compared with male
rats. The increased expression of the AT2-R in females is
in line with studies of the group of Denton et al., who
suggested that the AT2-R plays a role in the decreased
responsiveness to ang II of females (Sampson et al. 2008;
Brown et al. 2012; Safari et al. 2012; Sampson et al.
2012; Hilliard et al. 2013). As pointed out we infused
ang II for only 3 weeks. This resulted in relatively little
profibrotic damage and proteinuria, while we did not
observe renal damage (as characterized by glomerular
sclerosis - data not shown). The question arises whether
prolonged infusion or a combination of ang II infusion
with another hit (e.g. nephrectomy) does induce differ-
ences in renal damage in male and female rats. Moreover,
the present experiments (both human and rats) were
performed in young adults. Therefore, the differences
observed in the RAAS in the present study may not be
relevant to older individuals, such as older men and post-
menopausal women.
In conclusion, in both humans and rats, males seem to
have a higher vascular and renal sensitivity to ang II com-
pared to females. In response to acute ang II infusion,
men have a stronger rise in blood pressure and a stronger
ERPF response, but a decreased GFR response than
women. In rats, pressor responses during chronic ang II
infusion are also larger in males than in females, and
associated with a higher increase of proteinuria and intra-
renal inflammation in males. This study showed that
differences in function of the RAAS between males and
females, including differences in presence and function of
the AT2-R, could be an explanation for the gender differ-
ences in development of renal disease. Further research is
required to elucidate these gender differences in RAAS
regulation, which might contribute to a better view on
the differences in renal risk profile and treatment recom-
mendations between men and women.
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